The gut microbiota-derived metabolite indole-3-propionic acid enhances leptin sensitivity by targeting STAT3 against diet-induced obesity

Zhiwei Wang , Shaying Yang , Liangju Liu , Aiqin Mao , Hao Kan , Fan Yu , Xin Ma , Lei Feng , Tingting Zhou

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (12) : e70053

PDF
Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (12) : e70053 DOI: 10.1002/ctm2.70053
RESEARCH ARTICLE

The gut microbiota-derived metabolite indole-3-propionic acid enhances leptin sensitivity by targeting STAT3 against diet-induced obesity

Author information +
History +
PDF

Abstract

Obesity is associated with the gut microbiome. Here, we report that gut commensal Clostridia bacteria regulate host energy balance through the tryptophan-derived metabolite indole-3-propionic acid (IPA). IPA acts as an endogenous leptin sensitiser to counteract obesity. Mechanistically, IPA is secreted from the gut into the circulation, and then targets to the STAT3 in the hypothalamic appetite regulation centre, promoting its phosphorylation and nuclear translocation, which enhances the body’s response to leptin, and regulates the balance between appetite and energy metabolism. The in vitro pull-down assays involving site-directed mutagenesis demonstrate that Trp623 in the SH2 domain is the key binding site for STAT3-IPA interaction. High-fat diet (HFD), rather than genetic factors, induces excessive secretion of antimicrobial peptides by Paneth cells, inhibiting the growth of Clostridia in the gut and resulting in decreased production of the beneficial metabolite IPA. IPA or Clostridium sporogenes supplement effectively controls weight gain, improves glucose metabolism, and reduces inflammation in DIO mice. IPA fails to achieve such effects in ob/ob mice, while exogenous leptin administration restores the therapeutic effect of IPA. Our study suggests that the IPA-based gut-brain axis regulates host metabolism, and supplementation with microbiome-derived IPA could be a promising intervention strategy for treating obesity.

Keywords

gut microbiome / IPA / leptin sensitivity / metabolism / obesity / STAT3

Cite this article

Download citation ▾
Zhiwei Wang, Shaying Yang, Liangju Liu, Aiqin Mao, Hao Kan, Fan Yu, Xin Ma, Lei Feng, Tingting Zhou. The gut microbiota-derived metabolite indole-3-propionic acid enhances leptin sensitivity by targeting STAT3 against diet-induced obesity. Clinical and Translational Medicine, 2024, 14(12): e70053 DOI:10.1002/ctm2.70053

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

van der Klaauw AA, Farooqi IS. The hunger genes: pathways to obesity. Cell. 2015; 161: 119-132.

[2]

Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021; 143: e984-e1010.

[3]

Maffetone PB, Rivera-Dominguez I, Laursen PB. Overfat and underfat: new terms and definitions long overdue. Front Public Health. 2017; 4: 279.

[4]

Bouchard C, Tremblay A, Després JP, et al. The response to long-term overfeeding in identical twins. N Engl J Med. 1990; 322: 1477-1482.

[5]

Goodarzi MO. Genetics of obesity: what genetic association studies have taught us about the biology of obesity and its complications. Lancet Diabetes Endocrinol. 2018; 6(17): 223-236.

[6]

Popkin BM. Global nutrition dynamics: the world is shifting rapidly toward a diet linked with noncommunicable diseases. Am J Clin Nutr. 2006; 84: 289-298.

[7]

Pereira S, Cline DL, Glavas MM, et al. Tissue-specific effects of leptin on glucose and lipid metabolism. Endocr Rev. 2021; 42: 1-28.

[8]

Cui H, López M, Rahmouni K. The cellular and molecular bases of leptin and ghrelin resistance in obesity. Nat Rev Endocrinol. 2017; 13: 338-351.

[9]

Perakakis N, Farr OM, Mantzoros CS. Leptin in leanness and obesity: JACC state-of-the-art review. J Am Coll Cardiol. 2021; 77: 745-760.

[10]

Virtue AT, McCright SJ, Wright JM, et al. The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs. Sci Transl Med. 2019; 11(496): eaav1892.

[11]

Suárez-Zamorano N, Fabbiano S, Chevalier C, et al. Microbiota depletion promotes browning of white adipose tissue and reduces obesity. Nat Med. 2015; 21: 1497-1501.

[12]

Liu KH, Owens JA, Saeedi B, et al. Microbial metabolite delta-valerobetaine is a diet-dependent obesogen. Nat Metab. 2021; 3: 1694-1705.

[13]

Everard A, Belzer C, Geurts L, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A. 2013; 110: 9066-9071.

[14]

Aron-Wisnewsky J, Warmbrunn MV, Nieuwdorp M, et al. Metabolism and metabolic disorders and the microbiome: the intestinal microbiota associated with obesity, lipid metabolism, and metabolic health-pathophysiology and therapeutic strategies. Gastroenterology. 2021; 160: 573-599.

[15]

Serger E, Luengo-Gutierrez L, Chadwick JS, et al. The gut metabolite indole-3 propionate promotes nerve regeneration and repair. Nature. 2022; 607: 585-592.

[16]

Li Z, Zhang B, Wang N. A novel peptide protects against diet-induced obesity by suppressing appetite and modulating the gut microbiota. Gut. 2023; 72: 686-698.

[17]

Yang K, Niu J, Zuo T, et al. Alterations in the gut virome in obesity and type 2 diabetes mellitus. Gastroenterology. 2021; 161: 1257-1269.

[18]

Hoyles L, Fernández-Real JM, Federici M, et al. Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women. Nat Med. 2018; 24: 1070-1080.

[19]

Krautkramer KA, Fan J, Bäckhed F. Gut microbial metabolites as multi-kingdom intermediates. Nat Rev Microbiol. 2021; 19: 77-94.

[20]

Han S, Van Treuren W, Fischer CR, et al. A metabolomics pipeline for the mechanistic interrogation of the gut microbiome. Nature. 2021; 595: 415-420.

[21]

Dodd D, Spitzer MH, Van Treuren W. A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature. 2017; 551: 648-652.

[22]

Greer RL, Dong X, Moraes AC, et al. Akkermansia muciniphila mediates negative effects of IFNγ on glucose metabolism. Nat Commun. 2016; 7: 13329.

[23]

Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008; 29: 2959-2971.

[24]

Grant RW, Dixit VD. Adipose tissue as an immunological organ. Obesity (Silver Spring). 2015; 23: 512-518.

[25]

Brestoff JR, Artis D. Immune regulation of metabolic homeostasis in health and disease. Cell. 2015; 161: 146-160.

[26]

Ahima RS, Flier JS. Leptin. Annu Rev Physiol. 2000; 62: 413-437.

[27]

Huang L, Li C. Leptin: a multifunctional hormone. Cell Res. 2000; 10: 81-92.

[28]

Armen RS, Chen J. An evaluation of explicit receptor flexibility in molecular docking using molecular dynamics and torsion angle molecular dynamics. J Chem Theory Comput. 2009; 5: 2909-2923.

[29]

Ding X, Wu Y, Wang Y. Accelerated CDOCKER with GPUs, parallel simulated annealing, and fast Fourier transforms. J Chem Theory Comput. 2020; 16: 3910-3919.

[30]

Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021; 384: 989-1002.

[31]

Wharton S, Blevins T, Connery L, et al. Daily oral GLP-1 receptor agonist orforglipron for adults with obesity. N Engl J Med. 2023; 389: 877-888.

[32]

Berg AH, Kumar S, Karumanchi SA. Indoxyl sulfate in uremia: an old idea with updated concepts. J Clin Invest. 2022; 132: e155860.

[33]

Vanholder R, Schepers E, Pletinck A. The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review. J Am Soc Nephrol. 2014; 25: 1897-1907.

[34]

Grès S, Gomez-Zorita S, Gomez-Ruiz A, et al. 5-hydroxytryptamine actions in adipocytes: involvement of monoamine oxidase-dependent oxidation and subsequent PPARγ activation. J Neural Transm (Vienna). 2013; 120: 919-926.

[35]

Frazier K, Kambal A, Zale EA, et al. High-fat diet disrupts REG3γ and gut microbial rhythms promoting metabolic dysfunction. Cell Host Microbe. 2022; 30: 809-823.

[36]

Sun P, Wang M, Liu YX, et al. High-fat diet-disturbed gut microbiota-colonocyte interactions contribute to dysregulating peripheral tryptophan-kynurenine metabolism. Microbiome. 2023; 11(1): 154.

[37]

Morton GJ, Meek TH, Schwartz MW. Neurobiology of food intake in health and disease. Nat Rev Neurosci. 2014; 15: 367-378.

[38]

Liu J, Lee J, Salazar Hernandez MA, et al. Treatment of obesity with celastrol. Cell. 2015; 161: 999-1011.

[39]

Karbownik M, Reiter RJ, Garcia JJ, et al. Indole-3-propionic acid, a melatonin-related molecule, protects hepatic microsomal membranes from iron-induced oxidative damage: relevance to cancer reduction. J Cell Biochem. 2001; 81: 507-513.

[40]

Feng Y, Shen J, Lin Z, et al. PXR activation relieves deoxynivalenol-induced liver oxidative stress via Malat1 LncRNA m(6)A demethylation. Adv Sci (Weinh). 2024; 11: e2308742.

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

AI Summary AI Mindmap
PDF

222

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/